CLASS II Drug recall · Reported 22 Apr 2020 · FDA Enforcement Report

Estradiol, USP (Non-Micronized) (Hemihydrate) recalled

B & B Pharmaceuticals is recalling Estradiol, USP (Non-Micronized) (Hemihydrate), distributed nationwide in the US. The recall was initiated on 14 Apr 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 18K26-BB02-PR00553, Reassay 10/09/2023 Product # 700365, 700362 & 700363
Quantity recalled3,825 grams

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1244-2020
FDA event ID
85440
Recalling firm
B & B Pharmaceuticals, Englewood, CO
Classification
Class II
Status
Terminated
Recall initiated
14 Apr 2020
FDA classified
16 Apr 2020
Reported
22 Apr 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Foreign Material

Timeline

14 Apr 2020Recall initiated by company
16 Apr 2020Classified by FDA+2 days
22 Apr 2020Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 grams (NDC 63275-9900-5), c) 25 grams (NDC 63275-9900-4), Distributed by B&B Pharmaceuticals, Inc. 800-499-3100

Where it was distributed

USA Nationwide

Nationwide

Questions about this recall

Is Estradiol, USP (Non-Micronized) (Hemihydrate) recalled?

Yes. B & B Pharmaceuticals recalled Estradiol, USP (Non-Micronized) (Hemihydrate) on 14 Apr 2020. The recall is Class II and its status is Terminated. Recall number D-1244-2020.

Why was it recalled?

cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.

Which lots are affected?

Lot #: 18K26-BB02-PR00553, Reassay 10/09/2023 Product # 700365, 700362 & 700363

Where was it sold?

USA Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.